| Not Yet Recruiting | A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precurso Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia | Phase 3 | 2026-06-11 |
| Not Yet Recruiting | Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 1 | 2026-05-26 |
| Not Yet Recruiting | Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) Small Cell Lung Cancer | Phase 1 | 2026-05-05 |
| Recruiting | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Childre Generalized Myasthenia Gravis | Phase 2 | 2026-04-30 |
| Recruiting | Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® Du Neuromyelitis Optica Spectrum Disorder, Pregnancy Related | — | 2026-04-15 |
| Not Yet Recruiting | An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Thyroid Eye Disease | Phase 2 | 2026-04-14 |
| Not Yet Recruiting | Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmen Overweight, Obesity | Phase 1 | 2026-04-09 |
| Recruiting | Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) Ewing Sarcoma | Phase 1 | 2026-04-08 |
| Not Yet Recruiting | Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatri Immunoglobulin G4-related Disease | Phase 2 | 2026-04-03 |
| Recruiting | AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR) | Phase 1 | 2026-03-23 |
| Recruiting | Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiogra Cardiovascular Disease | Phase 3 | 2026-03-23 |
| Recruiting | Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta Osteogenesis Imperfecta | Phase 3 | 2026-03-18 |
| Recruiting | A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat an Overweight or Obesity and Elevated Liver Fat | Phase 2 | 2026-03-05 |
| Recruiting | A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Peglo Uncontrolled Gout | Phase 3 | 2026-02-09 |
| Recruiting | Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcu Healthy Participants, Pharmacokinetics | Phase 1 | 2026-01-16 |
| Recruiting | A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation Advanced Solid Tumors | Phase 2 | 2026-01-02 |
| Recruiting | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway P Obesity, Obstructive Sleep Apnea | Phase 3 | 2025-12-19 |
| Active Not Recruiting | A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Ad Overweight and Obesity | Phase 1 | 2025-12-15 |
| Recruiting | A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Le Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia, Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2025-12-08 |
| Recruiting | A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve M Metastatic Castration-resistant Prostate Cancer | Phase 3 | 2025-11-28 |
| Recruiting | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airw Obstructive Sleep Apnea | Phase 3 | 2025-11-25 |
| Active Not Recruiting | Effect of Maridebart Cafraglutide on the Heart's Electrical Activity Overweight, Obesity | Phase 1 | 2025-10-22 |
| Active Not Recruiting | Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administere Overweight, Obesity | Phase 1 | 2025-10-10 |
| Recruiting | Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor P Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Phase 1 | 2025-10-07 |
| Recruiting | A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (D Extensive Stage Small Cell Lung Cancer | Phase 1 | 2025-09-16 |
| Completed | A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intraven Healthy Volunteers | Phase 1 | 2025-08-26 |
| Recruiting | OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Ma Cardiovascular Disease | Phase 3 | 2025-08-22 |
| Recruiting | A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etopo Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer | Phase 3 | 2025-08-18 |
| Completed | Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients Non-Small Cell Lung Cancer | — | 2025-08-11 |
| Recruiting | A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Partic Type 2 Diabetes Mellitus | Phase 1 | 2025-08-05 |
| Recruiting | AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic So KRAS Altered Advanced or Metastatic Solid Tumors | Phase 1 | 2025-07-31 |
| Recruiting | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerot Atherosclerotic Cardiovascular Disease, Overweight, Obesity | Phase 3 | 2025-07-25 |
| Recruiting | A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis | Phase 2 | 2025-07-16 |
| Completed | Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients Thyroid Eye Disease | — | 2025-07-02 |
| Recruiting | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity | Phase 3 | 2025-06-25 |
| Active Not Recruiting | Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease Obesity Disease | Phase 3 | 2025-06-13 |
| Recruiting | A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteo Glucocorticoid-induced Osteoporosis | Phase 4 | 2025-05-24 |
| Recruiting | Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Partic Small Cell Lung Cancer | Phase 1 | 2025-05-16 |
| Completed | The Effect of AMG 133 on Gastric Emptying Overweight or Obesity | Phase 1 | 2025-04-17 |
| Terminated | Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants Healthy Volunteers | Phase 1 | 2025-04-08 |
| Active Not Recruiting | Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Ob Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Phase 3 | 2025-03-17 |
| Completed | A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Funct Hepatic Impairment | Phase 1 | 2025-03-14 |
| Active Not Recruiting | Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity Obesity | Phase 3 | 2025-03-12 |
| Completed | A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by t Overweight and Obesity | Phase 1 | 2025-03-11 |
| Active Not Recruiting | A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC Small Cell Lung Cancer (SCLC) | Phase 2 | 2025-02-26 |
| Recruiting | A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) Sjögren's Syndrome | Phase 3 | 2025-02-25 |
| Recruiting | Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) Relapsing-remitting Multiple Sclerosis (RRMS) | Phase 3 | 2025-01-13 |
| Completed | Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia B-precursor Acute Lymphoblastic Leukemia | Phase 1 | 2025-01-08 |
| Recruiting | A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) MTAP-deleted NSCLC | Phase 2 | 2024-12-26 |
| Completed | A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overwei Overweight, Obesity | Phase 1 | 2024-12-10 |
| Recruiting | Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Metastatic Castration-resistant Prostate Cancer | Phase 3 | 2024-12-09 |
| Recruiting | Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer Prostate Cancer | Phase 1 | 2024-11-25 |
| Completed | A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weig Obesity | — | 2024-11-14 |
| Active Not Recruiting | A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) Type 2 Diabetes Mellitus (T2DM) | Phase 2 | 2024-11-07 |
| Recruiting | Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children Vasculitis | Phase 3 | 2024-10-22 |
| Recruiting | A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and P Asthma | Phase 1 | 2024-10-16 |
| Recruiting | Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308) Extensive Stage Small Cell Lung Cancer | Phase 1 | 2024-10-07 |
| Active Not Recruiting | Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Ca Prostate Cancer, High-risk Biochemical Recurrence, High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer | Phase 1 | 2024-09-23 |
| Recruiting | Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homoz Thoracic Tumors, Non-small Cell Lung Cancer | Phase 1 | 2024-09-17 |
| Completed | A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants Basic Science | Phase 1 | 2024-09-12 |
| Active Not Recruiting | Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2024-09-12 |
| Recruiting | Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity Cardiometabolic Disease | Phase 1 | 2024-09-09 |
| Active Not Recruiting | A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squam Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer | Phase 3 | 2024-09-09 |
| Active Not Recruiting | Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Pri Extensive Stage Small Cell Lung Cancer | Phase 2 | 2024-08-27 |
| Completed | A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity Overweight, Obesity | Phase 1 | 2024-08-20 |
| Active Not Recruiting | Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China Osteoporosis | Phase 4 | 2024-08-06 |
| Completed | A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants Atopic Dermatitis | Phase 1 | 2024-08-06 |
| Active Not Recruiting | Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Ac B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia | Phase 2 | 2024-07-23 |
| Active Not Recruiting | A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis Prurigo Nodularis | Phase 3 | 2024-07-18 |
| Recruiting | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Metastatic Colorectal Cancer | Phase 3 | 2024-07-17 |
| Withdrawn | A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants Healthy Participants | Phase 1 | 2024-07-15 |
| Active Not Recruiting | A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Thyroid Eye Disease | Phase 3 | 2024-07-05 |
| Completed | A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease ( End-Stage Renal Disease (ESRD) | Phase 1 | 2024-06-18 |
| Active Not Recruiting | Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lun Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer | Phase 3 | 2024-06-05 |
| Recruiting | A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease Thyroid Eye Disease | Phase 1 / Phase 2 | 2024-05-30 |
| Recruiting | A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointest Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers | Phase 1 | 2024-05-29 |
| Active Not Recruiting | A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma Asthma | Phase 2 | 2024-05-24 |
| Active Not Recruiting | A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome Sjogren's Syndrome | Phase 2 | 2024-05-09 |
| Completed | A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight Obesity | Phase 1 | 2024-04-25 |
| Recruiting | Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents Osteogenesis Imperfecta | Phase 3 | 2024-04-22 |
| Active Not Recruiting | A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Sever Sjögren's Syndrome (SS) | Phase 3 | 2024-04-08 |
| Completed | A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopi Atopic Dermatitis | Phase 3 | 2024-04-02 |
| Active Not Recruiting | Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD) Neuromyelitis Optica Spectrum Disorder | Phase 4 | 2024-04-02 |
| Completed | A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared W Gout | Phase 4 | 2024-03-18 |
| Active Not Recruiting | A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-03-07 |
| Recruiting | Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer | Phase 3 | 2024-02-20 |
| Completed | A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants Atopic Dermatitis | Phase 1 | 2024-02-15 |
| Recruiting | A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 4 | 2024-02-07 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With M Sjogren's Syndrome | Phase 3 | 2024-01-24 |
| Completed | A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants Atopic Dermatitis | Phase 1 | 2024-01-23 |
| Completed | A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermat Idiopathic Inflammatory Myositis | Phase 2 | 2023-12-04 |
| Completed | A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Plaque Psoriasis | Phase 3 | 2023-11-27 |
| Recruiting | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as Non-Small Cell Lung Cancer (NSCLC) | Phase 3 | 2023-11-16 |
| Active Not Recruiting | A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Mela Melanoma | Phase 3 | 2023-11-02 |
| Completed | A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fractur Postmenopausal Osteoporosis | Phase 4 | 2023-10-30 |
| Active Not Recruiting | A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2023-10-24 |
| Withdrawn | Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppres Severe Aplastic Anemia (SAA) | Phase 2 | 2023-08-31 |
| Withdrawn | A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Relapsed/Refractory Multiple Myeloma | Phase 1 | 2023-08-29 |
| Active Not Recruiting | Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the B Giant Cell Tumor of Bone | Phase 4 | 2023-08-17 |
| Active Not Recruiting | A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors | Phase 1 / Phase 2 | 2023-08-01 |
| Completed | A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma Melanoma | Phase 3 | 2023-07-26 |
| Recruiting | Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder Neuromyelitis Optica Spectrum Disorder | Phase 2 | 2023-07-03 |
| Completed | Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tum Advanced Solid Tumors | Phase 1 | 2023-06-13 |
| Completed | A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCK Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis | Phase 3 | 2023-06-07 |
| Completed | Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 Atopic Dermatitis | EARLY_Phase 1 | 2023-06-03 |
| Active Not Recruiting | A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Partici Atopic Dermatitis | Phase 3 | 2023-05-31 |
| Active Not Recruiting | Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer Small Cell Lung Cancer (SCLC) | Phase 3 | 2023-05-31 |
| Terminated | Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerativ Ulcerative Colitis | Phase 2 | 2023-04-28 |
| Terminated | Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) Lupus Nephritis | Phase 2 | 2023-04-26 |
| Completed | A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatiti Atopic Dermatitis | Phase 3 | 2023-04-20 |
| Completed | A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Ad Healthy Volunteers | Phase 1 | 2023-03-24 |
| Recruiting | A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arth Behçet's Disease, Juvenile Psoriatic Arthritis | Phase 3 | 2023-03-23 |
| Withdrawn | Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refrac Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | 2023-03-13 |
| Terminated | A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell L Non-squamous Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors | Phase 1 | 2023-02-28 |
| Completed | A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitor Atopic Dermatitis | Phase 3 | 2023-02-21 |
| Completed | A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moder Atopic Dermatitis | Phase 3 | 2023-01-30 |
| Active Not Recruiting | A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Se Plaque Psoriasis | Phase 3 | 2023-01-25 |
| Completed | A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD) Chorioretinal Vascular Disease | Phase 3 | 2023-01-23 |
| Completed | Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overwe Obesity, Overweight, Type 2 Diabetes Mellitus | Phase 2 | 2023-01-18 |
| Terminated | Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus Discoid Lupus Erythematosus | Phase 2 | 2022-12-29 |
| Recruiting | A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascula Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease | — | 2022-12-19 |
| Completed | A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Hori Atopic Dermatitis | Phase 3 | 2022-12-14 |
| Active Not Recruiting | Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Atherosclerotic Cardiovascular Disease | Phase 3 | 2022-12-14 |
| Terminated | AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 1 | 2022-11-14 |
| Terminated | An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclero Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic | Phase 2 | 2022-11-04 |
| Active Not Recruiting | EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Cardiovascular Disease, Myocardial Infarction, Stroke | Phase 4 | 2022-10-26 |
| Completed | A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpres Solid Tumors | Phase 1 / Phase 2 | 2022-09-23 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Vario Hepatic Impairment | Phase 1 | 2022-09-13 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Norma Renal Impairment | Phase 1 | 2022-09-13 |
| Active Not Recruiting | First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensi Extensive Stage Small Cell Lung Cancer | Phase 1 | 2022-08-24 |
| Completed | Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obe Obesity | Phase 1 | 2022-07-26 |
| Completed | A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acid Healthy Volunteers | Phase 1 | 2022-07-14 |
| Completed | A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease Thyroid Eye Disease | Phase 1 | 2022-07-14 |
| Completed | Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of Simvastatin Healthy Volunteers | Phase 1 | 2022-06-28 |
| Terminated | Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension St Systemic Lupus Erythematosus | Phase 2 | 2022-06-01 |
| Completed | A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) Atopic Dermatitis | Phase 3 | 2022-05-31 |
| Active Not Recruiting | A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously U Gastric Cancer, Gastroesophageal Junction Cancer | Phase 1 / Phase 2 | 2022-05-17 |
| Completed | Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata Alopecia Areata | Phase 2 | 2022-04-27 |
| Active Not Recruiting | Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Colorectal Cancer (CRC) | Phase 3 | 2022-04-19 |
| Completed | A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardio Atherosclerotic Cardiovascular Disease | N/A | 2022-04-19 |
| Terminated | A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Ove Squamous-Cell Non-Small-Cell Lung Cancer | Phase 1 | 2022-03-29 |
| Completed | A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets Healthy Participants | Phase 1 | 2022-03-21 |
| Recruiting | Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis Active Juvenile Psoriatic Arthritis | Phase 3 | 2022-03-17 |
| Active Not Recruiting | Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untre Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2022-03-14 |
| Completed | Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) Palmoplantar Pustulosis | Phase 3 | 2022-03-08 |
| Active Not Recruiting | Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2 Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2022-03-07 |
| Active Not Recruiting | A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) Advanced MTAP-null Solid Tumors | Phase 1 / Phase 2 | 2022-02-01 |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2022-01-31 |
| Completed | A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation Non-small Cell Lung Cancer | Phase 2 | 2022-01-28 |
| Terminated | A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic P Idiopathic Pulmonary Fibrosis | Phase 2 | 2022-01-20 |
| Active Not Recruiting | A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) Relapsed/Refractory Small Cell Lung Cancer | Phase 2 | 2021-12-01 |
| Terminated | A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) Diffuse Cutaneous Systemic Sclerosis | Phase 1 | 2021-11-17 |
| Terminated | A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic | Phase 2 | 2021-11-05 |
| Recruiting | Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) | Phase 3 | 2021-11-02 |
| Completed | A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2021-10-04 |
| Completed | AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) Small Cell Lung Cancer | Phase 1 | 2021-09-27 |
| Completed | TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study Thyroid Eye Disease | Phase 4 | 2021-09-16 |
| Completed | Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants Healthy Participants | Phase 1 | 2021-09-10 |
| Recruiting | Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Behçet Disease | Phase 3 | 2021-09-09 |
| Completed | A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease | Phase 4 | 2021-09-02 |
| Terminated | Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer Non-small Cell Lung Cancer, NSCLC | Phase 1 | 2021-08-31 |
| Terminated | Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-pre B-precursor Acute Lymphoblastic Leukemia | Phase 4 | 2021-08-26 |
| Completed | Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants Healthy Participants | Phase 1 | 2021-08-20 |
| Completed | A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants Healthy Participants | Phase 1 | 2021-08-16 |
| Completed | Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants Inflammatory Diseases | Phase 1 | 2021-08-09 |
| Completed | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Pa Elevated Serum Lipoprotein(a) | Phase 1 | 2021-07-28 |
| Completed | A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (AB Adalimumab | Phase 1 | 2021-07-23 |
| Completed | A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases Dendritic Cell -Mediated Rheumatic Diseases | Phase 1 | 2021-07-06 |
| Completed | A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine Migraine | Phase 4 | 2021-06-11 |
| Completed | A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer Neuroendocrine Prostate Cancer | Phase 1 | 2021-06-10 |
| Completed | Study of VIB7734 for the Treatment of Moderate to Severely Active SLE Lupus Erythematosus, Systemic | Phase 2 | 2021-05-28 |
| Completed | Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease | Phase 1 | 2021-05-24 |
| Withdrawn | A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cance Metastatic Non-small Cell Lung Cancer (NSCLC), Non-squamous NSCLC | Phase 3 | 2021-05-15 |
| Terminated | Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus Active Systemic Lupus Erythematosus | Phase 2 | 2021-05-06 |
| Terminated | A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2021-04-29 |
| Completed | Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid T Advanced Solid Tumors | Phase 1 | 2021-04-29 |
| Completed | Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairm Hepatic Impairment | Phase 1 | 2021-04-22 |
| Completed | Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria | Phase 2 | 2021-04-15 |
| Completed | A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Psoriasis | Phase 3 | 2021-03-24 |
| Completed | Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegl Uncontrolled Gout | Phase 4 | 2021-03-08 |
| Recruiting | Aimovig Pregnancy Exposure Registry Migraine | — | 2021-01-27 |
| Completed | A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients Wi Uncontrolled Gout, Chronic Gout | Phase 4 | 2021-01-26 |
| Completed | Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta Osteogenesis Imperfecta | Phase 1 | 2021-01-21 |
| Terminated | Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2021-01-15 |
| Recruiting | A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL B Cell Precursor Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2021-01-04 |
| Active Not Recruiting | A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease IgG4 Related Disease | Phase 3 | 2020-12-04 |
| Completed | Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients COVID-19 | Phase 3 | 2020-11-24 |
| Completed | A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2020-11-11 |
| Completed | Biomarker and Genetic Predictors of Erenumab Treatment Response Migraine | Phase 4 | 2020-10-26 |
| Active Not Recruiting | Myasthenia Gravis Inebilizumab Trial Myasthenia Gravis | Phase 3 | 2020-10-15 |
| Completed | Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Chronic Uncontrolled Gout, Gout, Uncontrolled Gout | Phase 4 | 2020-10-02 |
| Completed | Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precur Acute Lymphoblastic Leukemia | Phase 1 | 2020-10-02 |
| Terminated | Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia Relapsed or Refractory Acute Myeloid Leukemia | Phase 1 | 2020-09-29 |
| Completed | A Study of TEPEZZA Subcutaneous Administration in Healthy Adults Bioavailability, Bioequivalence | Phase 1 | 2020-09-22 |
| Completed | Study of AMG 256 in Adult Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2020-09-15 |
| Completed | Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine Migraine | Phase 4 | 2020-09-15 |
| Completed | Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity Obesity | Phase 1 | 2020-08-07 |
| Completed | Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet Relapsed or Refractory Multiple Myeloma | Phase 2 | 2020-08-06 |
| Completed | Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study Cardiovascular Disease | Phase 2 | 2020-07-28 |
| Completed | A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Part Healthy Participants | Phase 1 | 2020-07-17 |
| Terminated | Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma Gastric and Gastroesophageal Junction Adenocarcinoma | Phase 1 | 2020-06-29 |
| Completed | A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Sufferi Neovascular (Wet) Age-related Macular Degeneration (AMD) | Phase 3 | 2020-06-22 |
| Active Not Recruiting | Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBr KRAS p, G12c Mutated /Advanced Metastatic NSCLC | Phase 3 | 2020-06-04 |
| Completed | AMG 510 Ethnic Sensitivity Study (CodeBreaK 105). Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation | Phase 1 | 2020-04-28 |
| Completed | A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Healthy Subjects | Phase 1 | 2020-03-11 |
| Completed | A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion Healthy Participants | Phase 1 | 2020-03-06 |
| Terminated | Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monit Heart Failure | N/A | 2020-03-06 |
| Recruiting | Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer Prostate Cancer | Phase 1 | 2020-03-04 |
| Active Not Recruiting | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Canc Chemotherapy-induced Thrombocytopenia | Phase 3 | 2020-02-26 |
| Completed | Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus (SLE) | Phase 2 | 2020-02-19 |
| Completed | Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy Melanoma | Phase 2 | 2020-01-22 |
| Terminated | Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Co MUC17-positive Solid Tumors | Phase 1 | 2020-01-20 |
| Completed | Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in He Healthy Participants | Phase 1 | 2020-01-06 |
| Withdrawn | Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Highly Sensitized Patients on Waiting List for Kidney Transplantation | Phase 2 | 2019-12-27 |
| Recruiting | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis Secondary Hyperparathyroidism | Phase 3 | 2019-12-20 |
| Completed | A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Psoriasis | Phase 3 | 2019-12-20 |
| Active Not Recruiting | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation | Phase 1 | 2019-12-17 |
| Terminated | Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity Obesity | Phase 1 | 2019-12-13 |
| Completed | A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2019-12-09 |
| Completed | A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome Sjögren's Syndrome | Phase 2 | 2019-12-09 |
| Terminated | The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) ASCVD | — | 2019-12-06 |
| Terminated | Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Migraine | Phase 4 | 2019-12-04 |
| Completed | A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 i Healthy Participants | Phase 1 | 2019-12-03 |
| Completed | A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Healthy Participants | Phase 1 | 2019-11-14 |
| Completed | Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants Healthy Volunteers | Phase 1 | 2019-11-13 |
| Completed | A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in H Electrocardiography | Phase 1 | 2019-11-08 |
| Completed | A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Healthy Participants | Phase 1 | 2019-11-05 |
| Completed | Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants Healthy Participants | Phase 1 | 2019-11-05 |
| Completed | A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Pro Allografts, Rejection; Transplant, Kidney, Transplant Rejection | Phase 2 | 2019-10-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pu Palmoplantaris Pustulosis | Phase 2 | 2019-10-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache Migraine Headache | Phase 4 | 2019-10-07 |
| Completed | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancre Chemotherapy-induced Thrombocytopenia | Phase 3 | 2019-09-30 |
| Completed | Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Relapsed Refractory Multiple Myeloma | Phase 4 | 2019-09-16 |
| Completed | Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Uncontrolled Gout, Kidney Transplant | Phase 4 | 2019-09-09 |
| Completed | Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Migraine | Phase 3 | 2019-09-05 |
| Completed | A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispe Healthy Volunteers | Phase 1 | 2019-08-28 |
| Completed | A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Ro Plaque Psoriasis | — | 2019-07-22 |
| Active Not Recruiting | Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine Migraine | Phase 3 | 2019-07-19 |
| Completed | A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Pso Plaque Psoriasis | Phase 3 | 2019-06-17 |
| Completed | Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout Gout | Phase 4 | 2019-06-13 |
| Completed | Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Coronary Heart Disease (CHD) | Phase 3 | 2019-06-11 |
| Completed | Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients Episodic Migraine | Phase 4 | 2019-05-15 |
| Terminated | Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participa Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | 2019-05-09 |
| Completed | A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone i Relapsed or Refractory Multiple Myeloma | Phase 3 | 2019-05-08 |
| Recruiting | A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disea Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | 2019-04-29 |
| Completed | A Controlled Trial of Erenumab in Migraine Prevention Migraine | Phase 3 | 2019-04-12 |
| Completed | A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifes Psoriasis | Phase 4 | 2019-03-28 |
| Terminated | A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Ato Atopic Dermatitis | Phase 2 | 2019-03-15 |
| Completed | Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Psoriasis | Phase 3 | 2019-03-11 |
| Completed | AMG 404 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-03-05 |
| Terminated | Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma Relapsed and/or Refractory Multiple Myeloma | Phase 1 | 2019-03-04 |
| Completed | An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis Psoriasis | Phase 3 | 2019-02-11 |
| Completed | A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment Arthritis, Psoriatic | — | 2019-02-06 |
| Completed | A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psori Psoriatic Arthritis | Phase 4 | 2019-02-06 |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | Phase 1 | 2019-02-05 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants Chronic Graft-versus-Host Disease (cGVHD) | Phase 1 | 2019-01-29 |
| Completed | A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2019-01-22 |
| Completed | Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. Arthritis, Psoriatic | Phase 4 | 2018-12-31 |
| Completed | Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AU Hidradenitis Suppurativa, Acne Inversa | Phase 2 | 2018-12-21 |
| Completed | Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With M Psoriasis | Phase 3 | 2018-12-19 |
| Completed | A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythemat Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren's Syndrome | Phase 1 | 2018-12-13 |
| Completed | Multiple Ascending Dose Study of AMG 598 in Adults With Obesity Obesity | Phase 1 | 2018-11-26 |
| Completed | Imaging of Coronary Plaques in Participants Treated With Evolocumab Coronary Artery Disease (CAD) | Phase 3 | 2018-11-19 |
| Withdrawn | An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipien Heart Transplantation, Elevated Resting Heart Rate | Phase 3 | 2018-11-02 |
| Terminated | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Dif Diffuse Large B-cell Lymphoma(DLBCL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma (FL) | Phase 1 | 2018-10-29 |
| Terminated | A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome Focal Segmental Glomerulosclerosis | Phase 2 | 2018-10-01 |
| Completed | Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout Gout | Phase 4 | 2018-09-26 |
| Completed | A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed Psoriasis | — | 2018-09-25 |
| Terminated | Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leuke Relapsed/Refractory Acute Myeloid Leukemia (AML) | Phase 1 | 2018-09-14 |
| Suspended | A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC Small Cell Lung Cancer | Phase 1 | 2018-09-10 |
| Active Not Recruiting | A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects Wi KRAS p.G12C Mutant Advanced Solid Tumors | Phase 1 / Phase 2 | 2018-08-27 |
| Terminated | Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractor Multiple Myeloma, Acute Myeloid Leukemia, Non-Hodgkins Lymphoma | Phase 1 | 2018-08-17 |
| Terminated | A Phase1 Study of VIB9600 Safety Issues | Phase 1 | 2018-08-14 |
| Completed | Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholeste Homozygous Familial Hypercholesterolemia HoFH | Phase 4 | 2018-08-04 |
| Completed | Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoria Arthritis, Psoriatic | — | 2018-07-31 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Cardiovascular Disease | Phase 1 | 2018-07-30 |
| Terminated | Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta Osteogenesis Imperfecta (OI) | Phase 3 | 2018-07-26 |
| Terminated | A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Communi Relapsed or Refractory Multiple Myeloma | Phase 2 | 2018-07-05 |
| Completed | Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremila Psoriasis | — | 2018-06-12 |
| Terminated | Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Pos High-risk Diffuse Large B-cell Lymphoma | Phase 2 | 2018-05-23 |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis Rheumatoid Arthritis RA | Phase 1 / Phase 2 | 2018-05-22 |
| Completed | A Study of CCX140-B in Subjects With FSGS FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis | Phase 2 | 2018-05-17 |
| Completed | Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyr Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | 2018-05-15 |
| Completed | Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With, Glucocorticoid-induced Osteoporosis | Phase 3 | 2018-05-07 |
| Completed | AMG 334 20160172 Pediatric Migraine PK Study. Migraine | Phase 1 | 2018-05-04 |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease Chronic Graft Versus Host Disease cGVHD | Phase 1 / Phase 2 | 2018-04-27 |
| Terminated | Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma Glioblastoma or Malignant Glioma | Phase 1 | 2018-04-18 |
| Completed | A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Im Hepatic Impairment | Phase 1 | 2018-04-17 |
| Completed | Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Ext Thyroid Eye Disease | Phase 3 | 2018-04-16 |
| Completed | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participan Systemic Lupus Erythematosus | Phase 1 | 2018-04-10 |
| Completed | Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer Wi Metastatic Triple Negative Breast Cancer, Metastatic Colorectal Cancer | Phase 1 | 2018-03-19 |
| Completed | Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With R Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Phase 1 | 2018-03-16 |
| Completed | A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 Secondary Hyperparathyroidism | Phase 1 | 2018-03-01 |
| Completed | Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Diso Urea Cycle Disorder | Phase 4 | 2018-02-20 |
| Completed | A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteopo Post-Menopausal Osteoporosis | Phase 3 | 2018-02-06 |
| Withdrawn | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma. Chemotherapy-induced Thrombocytopenia | Phase 3 | 2018-01-27 |
| Active Not Recruiting | Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung C Small Cell Lung Carcinoma | Phase 1 | 2017-12-26 |
| Completed | Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volu Heart Failure | Phase 1 | 2017-12-12 |
| Completed | Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 Giant Cell Tumor of Bone | Phase 4 | 2017-11-13 |
| Terminated | A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in S Relapsed/Refractory Multiple Myeloma | Phase 1 | 2017-11-13 |
| Completed | A Study of CCX168 in Japanese and Caucasian Healthy Adult Males Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 | 2017-10-23 |
| Completed | Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-pre Acute Lymphoblastic Leukemia | Phase 3 | 2017-10-18 |
| Completed | Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Ra Thyroid Eye Disease, Graves' Orbitopathy | Phase 3 | 2017-10-04 |
| Completed | Controlled Trial Evaluating Avacopan in C3 Glomerulopathy C3 Glomerulopathy (C3G) | Phase 2 | 2017-09-29 |
| Completed | A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dys Heart Failure (HF) | Phase 4 | 2017-09-28 |
| Completed | A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Bl Non-Hodgkin's Lymphoma | Phase 1 | 2017-09-18 |
| Terminated | Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | EARLY_Phase 1 | 2017-09-07 |
| Completed | Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention Chronic Migraine or Episodic Migraine | Phase 2 | 2017-09-06 |
| Completed | Post-Marketing Surveillance Study of OTEZLA Psoriasis | — | 2017-09-05 |
| Completed | Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors Advanced Non CNS Tumors | Phase 1 | 2017-08-16 |
| Completed | Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2017-08-14 |
| Completed | Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic In Melanoma, Herpetic Infection | — | 2017-08-10 |
| Completed | Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myel Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 3 | 2017-06-13 |
| Completed | A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroe Gastric or Gastroesophageal Cancer | Phase 1 | 2017-06-12 |
| Completed | Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection | Phase 3 | 2017-05-22 |
| Completed | A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psorias Psoriasis | Phase 3 | 2017-05-16 |
| Completed | AMG 529 First in Human Study Cardiovascular | Phase 1 | 2017-05-15 |
| Completed | A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgi Arthritis, Psoriatic | — | 2017-04-21 |
| Completed | A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium Psoriasis | — | 2017-04-06 |
| Completed | Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Mye Relapsed and Refractory Multiple Myeloma | Phase 3 | 2017-03-31 |
| Completed | Observational Study of Blinatumomab Blincyto Use in Routine Clinical Practice | — | 2017-03-22 |
| Completed | A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis ANCA-Associated Vasculitis | Phase 3 | 2017-03-15 |
| Completed | A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sH Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 1 | 2017-03-14 |
| Completed | Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe Multiple Myeloma | — | 2017-03-14 |
| Completed | Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma High-risk Diffuse Large B-Cell Lymphoma | Phase 2 | 2017-03-13 |
| Terminated | Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected Euro Dyslipidemia | Phase 3 | 2017-03-13 |
| Completed | Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Unresectable Stage IIIB-IV Malignant Melanoma | Phase 1 | 2017-03-07 |
| Completed | A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands Arthritis, Psoriatic | — | 2017-03-06 |
| Completed | APremilast After FumaRic Acid Ester Treatment Psoriasis | — | 2017-01-26 |
| Completed | Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B- B-Cell Non Hodgkin Lymphoma | Phase 2 / Phase 3 | 2017-01-23 |
| Completed | Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 | 2017-01-17 |
| Completed | A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis Postmenopausal Osteoporosis | Phase 3 | 2017-01-16 |
| Terminated | Study to Evaluate the Safety of Repatha® in Pregnancy Hypercholesterolaemia, Pregnancy | — | 2017-01-12 |
| Terminated | Evolocumab Pregnancy Exposure Registry Hypercholesterolemia; ASCVD; Pregnancy | — | 2016-12-22 |
| Completed | Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD Medical Conditions to be Studied, Dyslipidemia, ASCVD Management | — | 2016-12-06 |
| Completed | Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis, Rheumatoid; Arthritis, Psoriatic | Phase 3 | 2016-11-29 |
| Completed | Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Arthritis, Rheumatoid | Phase 3 | 2016-10-10 |
| Completed | Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipo Familial Hypercholesterolemia | Phase 3 | 2016-09-10 |
| Completed | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Exten Dyslipidemia | Phase 3 | 2016-09-02 |
| Completed | A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc | Phase 1 | 2016-08-26 |
| Completed | A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults Healthy Volunteers | Phase 1 | 2016-08-17 |
| Terminated | Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients Heart Failure, Healthy Volunteer | Phase 1 | 2016-08-12 |
| Completed | A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practic Psoriasis | — | 2016-06-30 |
| Completed | An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the U Relapsed/Refractory Acute Lymphoblastic Leukemia | — | 2016-06-30 |
| Completed | Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich' Friedreich's Ataxia | Phase 3 | 2016-06-28 |
| Completed | Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan Hypercholesterolemia, Familial Hypercholesterolemia | — | 2016-06-24 |
| Completed | Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Pharmacokinetics | Phase 1 | 2016-06-22 |
| Terminated | AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants Wit Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Acute Myeloid Leukemia | Phase 1 | 2016-06-13 |
| Completed | Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab Lymphoma, Non-Hodgkin | Phase 3 | 2016-05-25 |
| Completed | Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast Plaque Psoriasis | Phase 4 | 2016-05-18 |
| Completed | Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compar Arthritis, Rheumatoid | Phase 3 | 2016-05-17 |
| Completed | Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes | Phase 3 | 2016-05-17 |
| Completed | A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis Adult Onset Rheumatoid Arthritis | Phase 1 | 2016-05-12 |
| Completed | Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study RAS Wild Type mCRC | — | 2016-05-06 |
| Completed | Chart Review of Repatha® in Subjects With Hyperlipidaemia Hypercholesterolaemia | — | 2016-05-04 |
| Completed | Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in P Subjects With Hyperlipidemia, Dyslipidemia | Phase 3 | 2016-04-14 |
| Completed | Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemi Diabetes, Hyperlipidemia, Mixed Dyslipidemia | Phase 3 | 2016-04-14 |
| Completed | Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease Type II Refractory Celiac Disease (RCD-II), In-situ Small Bowel T-cell Lymphoma | Phase 2 | 2016-04-13 |
| Completed | A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease Celiac Disease | Phase 2 | 2016-04-13 |
| Completed | Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and N Carcinoma of the Head and Neck | Phase 1 | 2016-04-06 |
| Withdrawn | Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease Anemia, Chronic Kidney Disease | Phase 1 | 2016-04-01 |
| Completed | Single Ascending Dose Study of AMG 570 in Healthy Subjects Systemic Lupus Erythematosus | Phase 1 | 2016-03-28 |
| Completed | Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inh Heterozygous Familial Hypercholesterolemia | Phase 3 | 2016-03-24 |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4 Hypercholesterolemia | Phase 3 | 2016-02-27 |
| Completed | Observational Study of Apremilast in Patients With Psoriasis in The Netherlands Psoriasis | — | 2016-02-22 |
| Completed | Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatrip Healthy Subjects | Phase 1 | 2016-02-22 |
| Completed | Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions Arthritis, Psoriatic | — | 2016-02-18 |
| Completed | Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females Headache, Migraine | Phase 1 | 2016-02-12 |
| Completed | Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Sy Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node | Phase 1 / Phase 2 | 2016-02-05 |
| Completed | A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medic Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 | 2016-01-14 |
| Completed | A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention Migraine | Phase 2 | 2016-01-06 |
| Completed | Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Foo Healthy Volunteers | Phase 1 | 2016-01-05 |
| Completed | ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as Metastatic Colorectal Cancer | — | 2015-12-30 |
| Completed | Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study Friedreich's Ataxia | Phase 3 | 2015-12-25 |
| Completed | Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement Osteoporosis | Phase 4 | 2015-12-22 |
| Completed | Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment Hypercholesterolemia | Phase 3 | 2015-12-21 |
| Completed | A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 | 2015-12-03 |
| Completed | Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) Stable Angina | Phase 2 | 2015-11-23 |
| Completed | A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2015-11-20 |
| Completed | To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Migraine | Phase 1 | 2015-11-11 |
| Completed | Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse Leukemia, Acute Lymphoblastic | Phase 3 | 2015-11-10 |
| Completed | A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 59 Chronic Graft-versus-host Disease (cGVHD) | Phase 1 | 2015-10-19 |
| Completed | A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moder Psoriasis | Phase 2 | 2015-10-13 |
| Completed | Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refr Multiple Myeloma | Phase 3 | 2015-09-09 |
| Terminated | A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome | Phase 1 | 2015-08-31 |
| Completed | A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions Psoriasis | — | 2015-08-03 |
| Completed | Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Schizophrenia or Schizoaffective Disorder | Phase 1 | 2015-08-01 |
| Completed | Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 Schizophrenia or Schizoaffective Disorder | Phase 1 | 2015-08-01 |
| Completed | Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention Migraine | Phase 3 | 2015-07-20 |
| Completed | Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention Migraine | Phase 3 | 2015-07-17 |
| Terminated | Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI Osteogenesis Imperfecta | Phase 3 | 2015-06-24 |
| Completed | Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France Post Menopausal Osteoporosis | — | 2015-06-16 |
| Completed | Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | 2015-06-10 |
| Completed | Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2015-06-04 |
| Completed | Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Friedreich's Ataxia | Phase 3 | 2015-06-01 |
| Terminated | A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Ca Mitochondrial Diseases | Phase 2 | 2015-05-19 |
| Withdrawn | Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial Spondyloarthritis Axial Spondyloarthritis | Phase 2 | 2015-05-01 |
| Completed | Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multi Multiple Myeloma | Phase 1 | 2015-04-30 |
| Terminated | Safety Study of AMG 228 to Treat Solid Tumors Advanced Malignancy, Advanced Solid Tumors, Cancer | Phase 1 | 2015-04-21 |
| Completed | A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. Parapsoriasis | Phase 4 | 2015-04-20 |
| Completed | Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanom Unresected Stage IIIb to IVM1c Melanoma | Phase 2 | 2015-04-07 |
| Terminated | Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 1 | 2015-04-01 |
| Terminated | Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis Persistence to Enbrel | Phase 4 | 2015-04-01 |
| Completed | Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysi Renal Insufficiency, Chronic, Anemia, Renal Dialysis | Phase 4 | 2015-04-01 |
| Completed | Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blo Immunoglobulin A Nephropathy | Phase 2 | 2015-03-27 |
| Completed | Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2015-03-03 |
| Completed | Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission Rheumatoid Arthritis | Phase 3 | 2015-02-20 |
| Completed | Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Acute Lymphoblastic Leukemia (ALL) | Phase 1 | 2015-02-16 |
| Completed | Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis ANCA-associated Vasculitis | Phase 2 | 2015-02-04 |
| Completed | Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Me Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma | Phase 2 | 2015-02-03 |
| Completed | Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma Pancreatic Cancer | Phase 1 | 2015-02-01 |
| Completed | Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2015-01-08 |
| Completed | Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis | Phase 4 | 2015-01-01 |
| Completed | A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Urea Cycle Disorder | Phase 4 | 2014-12-31 |
| Completed | A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subje Behçet's Syndrome | Phase 3 | 2014-12-30 |
| Completed | Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) Immune Thrombocytopenia | Phase 3 | 2014-12-10 |
| Completed | Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) B-cell Precursor Acute Lymphoblastic Leukemia (ALL) | — | 2014-12-09 |
| Terminated | Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma Melanoma | Phase 3 | 2014-12-08 |
| Withdrawn | Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2014-12-01 |
| Terminated | A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer GI Adenocarcinoma | Phase 1 | 2014-11-27 |
| Completed | Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab Hypercholesterolemia | Phase 3 | 2014-11-24 |
| Completed | Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adul Healthy Volunteers | Phase 1 | 2014-11-24 |
| Completed | Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Us Metastatic Colorectal Cancer | — | 2014-11-21 |
| Terminated | Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 3 | 2014-11-07 |
| Completed | A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis Rheumatoid Arthritis | — | 2014-11-01 |
| Withdrawn | Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Solid Tumor, Metastatic Bone Disease | Phase 4 | 2014-11-01 |
| Completed | A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX16 Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 | 2014-10-20 |
| Completed | A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) Diabetic Macular Edema | Phase 1 | 2014-10-01 |
| Completed | Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects Dyslipidemia | Phase 3 | 2014-09-10 |
| Completed | Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on t Hyperlipidemia, Mixed Dyslipidemia | Phase 1 | 2014-08-19 |
| Terminated | A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Toler Advanced Non-Central Nervous System (CNS) Malignancies | Phase 1 | 2014-08-01 |
| Terminated | A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refrac Multiple Myeloma | Phase 1 | 2014-07-30 |
| Completed | Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Ca Chemotherapy-induced Febrile Neutropenia | — | 2014-07-18 |
| Completed | Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody Primary Hyperlipidemia and Mixed Dyslipidemia | Phase 3 | 2014-07-08 |
| Terminated | A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Gastric Cancer | Phase 3 | 2014-07-01 |
| Completed | Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Immune Thrombocytopenic Purpura | — | 2014-07-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Sub Chronic Rhinosinusitis With Nasal Polyps | Phase 1 | 2014-07-01 |
| Completed | A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. Treatment for Prevention of Chronic Migraine | Phase 2 | 2014-06-30 |
| Completed | A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis Osteoporosis in Men | Phase 3 | 2014-06-16 |
| Completed | Darbepoetin Alfa MDS Companion Protocol Myelodysplastic Syndrome (MDS) | Phase 3 | 2014-06-12 |
| Completed | Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Anaemia, Chronic Kidney Disease (CKD) | — | 2014-06-01 |
| Completed | Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic Dermatitis | Phase 2 | 2014-06-01 |
| Completed | Study of Haemodialysis Patients Switching From Aranesp to Biosimilar Anaemia | — | 2014-06-01 |
| Terminated | Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Health Migraine | Phase 1 | 2014-05-01 |
| Completed | A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Pos Postmenopausal Osteoporosis | Phase 3 | 2014-05-01 |
| Completed | Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease Inherited Mitochondrial Disease, Including Leigh Syndrome | Phase 2 | 2014-05-01 |
| Completed | A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects Stomach Neoplasms | Phase 1 / Phase 2 | 2014-04-15 |
| Completed | Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec Melanoma | Phase 2 | 2014-04-07 |
| Completed | Effect of Denosumab on Cellular Biomarkers in the Human Breast Healthy Volunteer, Female, Breast | Phase 1 | 2014-04-01 |
| Completed | Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 3 | 2014-04-01 |
| Completed | Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidne Hyperparathyroidism, Secondary | Phase 3 | 2014-03-25 |
| Completed | A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention Treatment for Prevention of Chronic Migraine | Phase 2 | 2014-03-05 |
| Completed | Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis | Phase 1 | 2014-02-07 |
| Terminated | Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors Stomach Neoplasms | Phase 2 | 2014-02-01 |
| Completed | Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug Product Healthy Volunteer | Phase 1 | 2014-02-01 |
| Completed | Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men Healthy Volunteers | Phase 1 | 2014-01-07 |
| Completed | Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia Relapsed/Refractory Philadelphia Positive B-precursor ALL | Phase 2 | 2014-01-03 |
| Terminated | Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Phase 3 | 2014-01-03 |
| Completed | Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark XGEVA Off-label Use | — | 2014-01-01 |
| Completed | Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease Relapsed Multiple Myeloma, End-stage Renal Disease | Phase 1 | 2014-01-01 |
| Completed | A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multipl Multiple Myeloma | Phase 1 / Phase 2 | 2014-01-01 |
| Completed | Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2013-12-31 |
| Completed | Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3 Hyperlipidemia | Phase 3 | 2013-12-10 |
| Completed | A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporos Postmenopausal Osteoporosis | Phase 3 | 2013-12-03 |
| Completed | Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung C Non-small Cell Lung Cancer Metastatic | Phase 3 | 2013-11-11 |
| Completed | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive St Extensive-Stage Small-Cell Lung Cancer | Phase 1 / Phase 2 | 2013-11-05 |
| Terminated | Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma | Phase 1 / Phase 2 | 2013-10-28 |
| Completed | Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Pla Psoriasis | Phase 3 | 2013-10-18 |
| Completed | Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Imp Solid Tumors, Hematologic Malignancies, Hepatic Impairment | Phase 1 | 2013-10-01 |
| Completed | Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Art Arthritis, Rheumatoid | Phase 3 | 2013-10-01 |
| Completed | Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With Migraines Migraine | Phase 1 | 2013-10-01 |
| Completed | Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events | Phase 3 | 2013-10-01 |
| Completed | Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukem Acute Lymphoblastic Leukemia | — | 2013-10-01 |
| Terminated | Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) Urea Cycle Disorder | — | 2013-09-25 |
| Completed | Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2013-09-04 |
| Completed | Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients Acute Lymphoblastic Leukemia | — | 2013-09-01 |
| Completed | Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | 2013-08-13 |
| Completed | Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SH Hyperparathyroidism, Secondary | Phase 3 | 2013-08-12 |
| Completed | Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention Migraine | Phase 2 | 2013-08-06 |
| Completed | A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. Asthma | Phase 1 | 2013-08-01 |
| Completed | A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnose Multiple Myeloma | Phase 1 | 2013-08-01 |
| Completed | Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chr Hyperparathyroidism, Secondary | Phase 3 | 2013-07-31 |
| Completed | Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a P Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | 2013-07-11 |
| Completed | Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe P Psoriasis, Psoriatic Arthritis, Psoriasis Arthropatica | Phase 2 | 2013-07-09 |
| Completed | Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Mu Multiple Myeloma | Phase 3 | 2013-07-08 |
| Terminated | Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refr Multiple Myeloma | Phase 1 / Phase 2 | 2013-07-02 |
| Completed | Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease Thyroid Associated Ophthalmopathies, Thyroid-Associated Ophthalmopathy | Phase 2 | 2013-07-01 |
| Completed | Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use Rheumatoid Arthritis, Psoriatic Arthritis | Phase 3 | 2013-06-11 |
| Completed | Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With E Rheumatoid Arthritis, Plaque Psoriasis | Phase 4 | 2013-06-05 |
| Completed | Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous D Healthy Volunteer | Phase 1 | 2013-06-01 |
| Terminated | Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma Asthma | Phase 2 | 2013-05-22 |
| Completed | Study of Erenumab (AMG 334) in Women With Hot Flashes Vasomotor Symptoms; Hot Flashes | Phase 1 | 2013-05-13 |
| Terminated | Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to A Moderate to Severe Rheumatoid Arthritis | Phase 4 | 2013-05-06 |
| Completed | Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer Breast Cancer | Phase 3 | 2013-04-29 |
| Completed | Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia Hyperlipidemia and Mixed Dyslipidemia | Phase 3 | 2013-04-23 |
| Completed | Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment Osteoporosis | Phase 1 | 2013-04-22 |
| Completed | Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | 2013-04-18 |
| Completed | GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound Hypercholesterolemia | Phase 3 | 2013-04-18 |
| Terminated | Study of South African Dialysis Patients Chronic Kidney Disease, Receiving Dialysis | — | 2013-04-01 |
| Completed | Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Pat Hyperparathyroidism, Secondary | Phase 3 | 2013-03-12 |